MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Patient perspectives on symptoms and functional impacts to inform a digital assessment of Parkinson’s disease

    B. Fehlmann, A. Thomann, E. Davies, J. Twiss, C. Romano, D. Whalley, M. Mayorga, C. Levy, F. Lipsmeier, W. Popp, T. Kustermann, H. Svoboda, T. Nikolcheva, D. Trundell, M. Lindemann, K. Taylor (demuro)

    Objective: The aim of this study is to map patients’ reports of functional limitations and impacts of Parkinson’s disease (PD) to motor signs captured with…
  • 2023 International Congress

    Angiotensin II Type 1 (AT1) receptor antagonists as potential candidates for anxiety treatment in Parkinson’s Disease

    S. Bordet, L. Grasso, L. Udovin, G. Chevalier, M. Otero-Losada, F. Capani, S. Perez-Lloret (Buenos Aires, Argentina)

    Objective: The aim of this study was to explore the effects of Angiotensin II Type 1 receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) on…
  • 2023 International Congress

    Dysconnectivity of the Parafascicular Nucleus in Parkinson’s Disease

    L. Chen, T. Wu (Beijing, China)

    Objective: The present study aimed to investigate the functional alterations of the parafascicular nucleus (Pf) projections in Parkinson’s disease (PD) patients. Background: Recent animal model…
  • 2023 International Congress

    White matter lesions and motor symptoms in Parkinson’s disease

    S. Jost, A. Sauerbier, A. Rizos, M. Picillo, D. van Wamelen, V. Stopic, JN. Petry-Schmelzer, M. Schönfeld, N. Abdullayev, K. Ashkan, K. Rukavina, J. Jarosz, M. Sommerauer, M. Qamar, R. Cury, E. Fonoff, M. Dos Santos-Ghilardi, A. Othman, M. Muthuraman, GR. Fink, A. Antonini, L. Timmermann, P. Martinez-Martin, A. Fasano, K. Ray Chaudhuri, H. Dafsari (Cologne, Germany)

    Objective: Objective: To investigate the association between cerebral white matter lesions (WML) and motor symptoms in Parkinson’s disease (PD). Background: Background: Previous studies have shown…
  • 2023 International Congress

    A benign course of Parkinson’s disease associated with different mutations in the glucocerebrosidase gene – a case series

    G. Yahalom, A. Faust-Socher, M. Cohen, Y. Schechter, M. Becker-Cohen, R. Eichel, S. Revel-Vilk, A. Zimran (Jerusalem, Israel)

    Objective: Herein we describe 5 cases of GBA-related PD patients with a markedly benign course. Background: Subjects carrying mutations in the GBA1 gene, whether in…
  • 2023 International Congress

    Utilizing Speech Analysis to Differentiate Progressive Supranuclear Palsy from Parkinson Disease

    K. Kang, A. Nunes, M. Sharma, A. Hall, R. Mishra, J. Casado, R. Cole, G. Barchard, A. Vaziri, A. Wills, A. Pantelyat (Baltimore, USA)

    Objective: To differentiate Progressive Supranuclear Palsy (PSP) from Parkinson Disease (PD) using speech analysis. Background: PD and PSP exhibit many clinical similarities including speech disorders…
  • 2023 International Congress

    Effect of levodopa on the interpretation of social interactions in people living with Parkinson’s disease

    T. Danaila, E. Metereau (Bron, France)

    Objective: Better understand the social interactions by assessing the effect of oral levodopa on the social cognition abilities in fluctuating PD patients without significant cognitive disorder.…
  • 2023 International Congress

    Changes in word fluency tasks and cognitive function before and after the COVID-19 epidemic in patients with Parkinson’s disease:PD.

    M. Sagawa, K. Hasegawa, A. Kumon, M. Saruwatari (Kanagawa, Japan)

    Objective: The purpose of this study is to investigate the changes in cognitive function and frontal lobe function in PD before and after self-restraint due…
  • 2023 International Congress

    Neurophysiological markers of motor reserve in Parkinson’s disease

    M. Passaretti, S. Rinaldo, E. Orunesu, D. Rossi Sebastiano, G. de Vigili, G. Barbiera, A. Braccia, G. Paparella, M. de Riggi, P. Lanteri, A. Berardelli, A P. Strafella, M. Bologna, R. Eleopra, R. Cilia (Rome, Italy)

    Objective: Our objective was to investigate Motor Reserve (MR) in idiopathic Parkinson’s Disease (PD). Background: MR is defined as the resilience mechanisms of the brain…
  • 2023 International Congress

    Impact of the severity of Parkinson’s disease on skin elasticity

    SY. You, HJ. Park (Daegu, Republic of Korea)

    Objective: To investigate changes in skin elasticity according to the severity of symptoms of Parkinson's disease. Background: Parkinson's disease (PD) is a neurodegenerative disease caused…
  • « Previous Page
  • 1
  • …
  • 234
  • 235
  • 236
  • 237
  • 238
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley